2025
SJR Q1
JCR Q2 · 3,3
53 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Neuroradiology
- Yayıncı
- Elsevier Masson s.r.l.
- Ülke
- France · Western Europe
- Tür
- journal
- ISSN
-
0150986117730406
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,972
- Quartile Q1
- H-Index 55
- Atıf/yayın 2,83
- Doküman (3y) 223
- Atıf (3y) 633
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,3
- 5Y JIF 3,2
- JCI 1,02
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Neurology (clinical) Q2
- Radiological and Ultrasound Technology Q1
- Radiology, Nuclear Medicine and Imaging Q1
Alanlar
- Health Professions
- Medicine
WoS kategorileri
- Clinical Neurology | Neuroimaging | Radiology, Nuclear Medicine & Medical Imaging
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,972 | 3,3 | 3,2 | 1,02 | Q1 | 55 |
| 2024 | Q1 | Q1 | 0,928 | 3,3 | 3,1 | 1,04 | Q1 | 53 |
| 2023 | Q2 | Q2 | 0,756 | 3 | 2,9 | 1,01 | Q1 | 53 |
| 2022 | Q2 | Q2 | 0,75 | 3,5 | 2,9 | 0,92 | Q2 | 53 |
| 2021 | Q1 | Q2 | 1,057 | 4,6 | 3,3 | 0,83 | Q2 | 53 |
| 2020 | Q1 | Q2 | 0,905 | 3,4 | 2,9 | 0,74 | Q2 | 53 |
| 2019 | Q2 | Q2 | 0,727 | 2,4 | 2,4 | 0,62 | Q2 | 53 |
| 2018 | — | Q2 | — | 2,5 | 2,2 | 0,62 | Q2 | — |
| 2017 | Q1 | Q2 | 0,985 | 2,7 | 2,1 | 0,61 | Q2 | 53 |
| 2016 | Q2 | Q2 | 0,763 | 2,5 | 1,7 | — | — | 53 |
| 2015 | Q2 | Q2 | 0,753 | 2,8 | 1,8 | — | — | 53 |
| 2014 | Q2 | Q2 | 0,585 | 1,8 | 1,6 | — | — | 53 |
| 2013 | Q2 | Q3 | 0,522 | 1,1 | 1,2 | — | — | 53 |
| 2012 | Q2 | Q3 | 0,475 | 1,2 | 1,3 | — | — | 53 |
| 2011 | Q2 | Q3 | 0,549 | 1,2 | 1,3 | — | — | 53 |
| 2010 | Q2 | Q3 | 0,603 | 1,2 | 1,1 | — | — | 53 |
| 2009 | — | Q3 | — | 1,2 | 1 | — | — | — |
| 2008 | — | Q3 | — | 1,4 | 0,9 | — | — | — |
| 2007 | — | Q4 | — | 0,9 | 0,8 | — | — | — |
| 2006 | — | Q4 | — | 0,5 | — | — | — | — |
| 2005 | — | Q4 | — | 0,6 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q3 | — | 0,6 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
| 2001 | — | Q3 | — | 0,6 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q4 | — | 0,5 | — | — | — | — |
| 1998 | — | Q4 | — | 0,4 | — | — | — | — |
| 1997 | — | Q3 | — | 0,6 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q2 | Q1 | 107/296 |
| 2025 | NEUROIMAGING | SCIE | Q2 | Q2 | 7/18 |
| 2025 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q1 | 62/217 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q2 | Q1 | 90/286 |
| 2024 | NEUROIMAGING | SCIE | Q2 | Q1 | 5/16 |
| 2024 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | Q1 | 46/213 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 98/280 |
| 2023 | NEUROIMAGING | SCIE | Q2 | Q2 | 6/15 |
| 2023 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q1 | 52/204 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 86/212 |
| 2022 | NEUROIMAGING | SCIE | Q2 | Q2 | 5/14 |
| 2022 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 38/135 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 69/212 |
| 2021 | NEUROIMAGING | SCIE | Q2 | Q2 | 6/14 |
| 2021 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 43/136 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q2 | Q2 | 98/208 |
| 2020 | NEUROIMAGING | SCIE | Q2 | Q2 | 7/14 |
| 2020 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 53/133 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 113/204 |
| 2019 | NEUROIMAGING | SCIE | Q3 | Q3 | 8/14 |
| 2019 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 64/134 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 113/199 |
| 2018 | NEUROIMAGING | SCIE | Q3 | Q3 | 8/14 |
| 2018 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 58/129 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q2 | Q3 | 96/197 |
| 2017 | NEUROIMAGING | SCIE | Q2 | Q3 | 7/14 |
| 2017 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 41/129 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 92/194 |
| 2016 | NEUROIMAGING | SCIE | Q2 | — | 7/14 |
| 2016 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 41/127 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 71/193 |
| 2015 | NEUROIMAGING | SCIE | Q2 | — | 7/14 |
| 2015 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 33/124 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 126/192 |
| 2014 | NEUROIMAGING | SCIE | Q4 | — | 11/14 |
| 2014 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 62/125 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 159/194 |
| 2013 | NEUROIMAGING | SCIE | Q4 | — | 13/14 |
| 2013 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 90/122 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 148/193 |
| 2012 | NEUROIMAGING | SCIE | Q4 | — | 11/14 |
| 2012 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 84/120 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 149/192 |
| 2011 | NEUROIMAGING | SCIE | Q4 | — | 11/14 |
| 2011 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 85/116 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 136/185 |
| 2010 | NEUROIMAGING | SCIE | Q3 | — | 10/14 |
| 2010 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 82/113 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 125/167 |
| 2009 | NEUROIMAGING | SCIE | Q3 | — | 9/13 |
| 2009 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 76/104 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 106/156 |
| 2008 | NEUROIMAGING | SCIE | Q3 | — | 9/12 |
| 2008 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 63/92 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 115/146 |
| 2007 | NEUROIMAGING | SCIE | Q4 | — | 11/13 |
| 2007 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 72/87 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 133/147 |
| 2006 | NEUROIMAGING | SCIE | Q4 | — | 12/13 |
| 2006 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 81/85 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 126/148 |
| 2005 | NEUROIMAGING | SCIE | Q4 | — | 11/14 |
| 2005 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 77/84 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 104/140 |
| 2004 | NEUROIMAGING | SCIE | Q3 | — | 8/14 |
| 2004 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 64/84 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 117/135 |
| 2003 | NEUROIMAGING | SCIE | Q3 | — | 9/13 |
| 2003 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 76/83 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 117/138 |
| 2002 | NEUROIMAGING | SCIE | Q4 | — | 10/13 |
| 2002 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 73/81 |
| 2001 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 102/136 |
| 2001 | NEUROIMAGING | SCIE | Q4 | — | 12/15 |
| 2001 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 68/81 |
| 2000 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 113/137 |
| 2000 | NEUROIMAGING | SCIE | Q4 | — | 12/15 |
| 2000 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 71/80 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 107/132 |
| 1999 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 64/78 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 108/125 |
| 1998 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | — | 68/79 |
| 1997 | CLINICAL NEUROLOGY | SCIE | Q4 | — | 82/107 |
| 1997 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | — | 56/75 |